Sun Pharma and its subsidiary has been granted approval for its application for Nicardipine Hydrochloride Injections by the USFDA. These Nicardipine Hydrochloride Injections are available as 25 mg/10ml single use ampuls containing 2.5 mg/ml of the drug, and have annual sales of approximately USD 170 million in the US. These injections are used for the short-term treatment of hypertension when oral therapy is not feasible or not desirable.
No comments:
Post a Comment